Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | FLT1 | P17948 | 1/20 | 0.30 |
| ▸ | FLT4 | P35916 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31365025 | 0.91 | TP53 (0.43) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31365031 | 0.90 | LMNA (0.39) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31365033 | 0.81 | TNF (0.36) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31365037 | 0.81 | TP53 (0.45) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31364893 | 0.78 | TP53 (0.42) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31364831 | 0.76 | TP53 (0.40) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31365016 | 0.75 | TSHR (0.37) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31364929 | 0.74 | TNF (0.37) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31364959 | 0.73 | TP53 (0.45) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL31364997 | 0.71 | LMNA (0.43) | LMNATP53HTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025056065-A1 | CHEMOKINE RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION, AND USE | 上海医药集团股份有限公司 | 2025-03-20 | — | — | WO | disclosed |